DACIA NEUFFER: Open Payments
NPI 1376710319 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 31 payments from 17 companies in 2025. Trend: 2023 $228 · 2024 $444 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $138 |
| ABBVIE INC. | 2 | $135 |
| Incyte Corporation | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $111 |
| Organon LLC | 5 | $97 |
| KYOWA KIRIN, INC. | 3 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $36 |
| GENZYME CORPORATION | 1 | $33 |
| Lilly USA, LLC | 2 | $32 |
Products named: OTEZLA, COSENTYX, SKYRIZI, Opzelura, DUPIXENT, VTAMA, POTELIGEO, LIBTAYO.
Industry payments across AZ — which companies pay providers there.
